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doi:10.1016/j.jinf.2011.06.005Summary Objective: Many fundamental patterns of coinfection (multi-species infections)
are undescribed, including the relative frequency of coinfection by various pathogens, differ-
ences between single-species infections and coinfection, and the burden of coinfection on hu-
man health. We aimed to address the paucity of general knowledge on coinfection by
systematically collating and analysing data from recent publications to understand the types
of coinfection and their effects.
Methods: From an electronic search to find all publications from 2009 on coinfection and its
synonyms in humans we recorded data on i) coinfecting pathogens and their effect on ii) host
health and iii) intensity of infection.
Results: The most commonly reported coinfections differ from infections causing highest
global mortality, with a notable lack of serious childhood infections in reported coinfections.
We found that coinfection is generally reported to worsen human health (76% publications) and
exacerbate infections (57% publications). Reported coinfections included all kinds of patho-
gens, but were most likely to contain bacteria.
Conclusions: These results suggest differences between coinfected patients and those with
single infections, with coinfection having serious health effects. There is a pressing need to
quantify the tendency towards negative effects and to evaluate any sampling biases in the cov-
erage of coinfection research.
ª 2011 The British Infection Association. Published by Elsevier Ltd.
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The many pathogens that infect humans (e.g., viruses,
bacteria, protozoa, fungal parasites, helminths) often co-
occur within individuals.1e5 Helminth coinfections alone
are thought to occur in over 800 million people,6 and are es-
pecially prevalent among the global poor.7e9 Other coinfec-
tions involve globally important diseases such as HIV,10
tuberculosis,11 malaria,12 hepatitis,13 leishmaniasis,14 and
dengue fever.15 It seems likely, therefore, that the true
prevalence of coinfection exceeds one sixth of the global
population and often involves infectious diseases of press-
ing human concern.
Improved understanding of coinfection prevalence is
greatly needed,16 partly because coinfecting pathogens
can interact either directly with one another or indirectly
via the host’s resources or immune system.3 Compared to
infections of single pathogen species, these interactions
within coinfected hosts can alter the transmission, clinical
progression and control of multiple infectious dis-
eases.17e19 Establishing the nature and consequences of co-
infection requires integrated monitoring and research of
different infectious diseases,1 but such data are rare.9,20,21
Reviews of coinfection have emphasised that coinfection
requires further research, especially in humans,2,3,20,22
where coinfection outnumbers single infection in many
communities2,23 and where helminth coinfections appear
to worsen human health.20 Coinfection involves a range of
pathogens and can have various effects on coinfected
hosts.3 There are many individual studies concerning coin-
fection, but these use various approaches and are often
narrowly focused. We aimed to gain a coherent picture of
the nature and consequences of coinfection in humans.
We surveyed the published literature for the occurrence
of coinfecting pathogens and their effects on other infect-
ing organisms and human health. We found that coinfec-
tions involve a huge variety of pathogens, and most
studies report negative effects on human health. However,
current coinfection research rarely focuses on pathogens
with highest global mortality.
Materials and methods
Literature search
We searched the published literature for studies of co-
infection (i.e. multi-species infections) in humans using the
Advanced Search facility on the largest online citation
database, Scopus (Elsevier Ltd.). Many disciplines study
infectious diseases and various terms are used to describe
coinfection. We therefore searched for coinfection, con-
comitant infection, multiple infection, concurrent infec-
tion, simultaneous infection, double infection,
polymicrobial, polyparasitism, or multiple parasitism in
the Title, Abstract, or Keywords of publications in the
Life and Health Sciences before 2010. In June 2011 this
search returned 12,963 results; an equivalent search on an
alternative online citation database, Web of Science
[Thomson Reuters], yielded similar trends in publications
through time, but fewer results. Due to the large number of
publications matching the search terms, we chose to focuson publications from 2009. Furthermore, publications con-
cerning non-human hosts, non-infectious diseases or multi-
ple genotypes of only one pathogen species were excluded.
For each publication we collected data on the identity of
coinfecting pathogens, journal, study type and maximum
number of pathogen species found per person. Study types
included experiments treating each infection, observa-
tional studies, and reviews/meta-analyses. Observational
studies were either case notes on particular patients,
studies of patient groups, or epidemiological surveys among
human communities.
Many publications reported the stated effect of one
pathogen on the abundance of coinfecting pathogens (i.e.
proxies for the intensity of infection, e.g. from measures of
viral load, faecal egg counts, antibody response, bacterial
cultures etc.) and/or host health (e.g. survival, recovery
time, anaemia, liver fibrosis, immune cell counts). These
effects of coinfection are relative to conditions observed
under infections of single pathogen species. Where these
effects were reported we recorded the pair of coinfecting
pathogens involved, the quality of measurement (rated as
low [e.g. anecdotal], adequate [e.g. correlation] and high
[i.e. full reporting of appropriate statistical test supported
by theoretical mechanisms]) and other data (see below).
Data from review-type publications, case notes and from
publications not mentioning the effects of coinfection (120
publications for pathogen abundance and 110 for host
health) were excluded to avoid double counting, undue
influence of individual cases and the inclusion of irrelevant
publications. Reported effects based on low quality evi-
dence (10 publications for pathogen abundance and 24 for
host health) were also omitted.
Analyses of the effects of coinfection
There was considerable heterogeneity in the reporting of
the effects of coinfection, both in terms of the response
variable and in terms of the quantitative measure given
(e.g. odds ratios, adjusted odds ratios, P-values, hazards
ratios, raw comparisons). Furthermore, many publications
gave qualitative statements of effect direction. Among
publications quantifying effect size, diverse measures
were given across publications. We focused on the direction
of reported effects (positive, negative and no-effect) to
maximise the data available. Reported directions of the ef-
fects on both pathogen abundance and host health for each
pair of coinfecting pathogens was coded þ1 for positive ef-
fect, 0 for neutral, 1 for negative effects, and NA if no in-
formation about effect direction was given. The resulting
dataset includes some repeated measures because some
publications reported multiple pairs of coinfecting patho-
gens and some coinfections were reported in multiple pub-
lications. We created two independent datasets containing
the mean effect direction (i) per publication and (ii) per co-
infection to eliminate these sources of pseudoreplication. A
negative mean implied a predominance of negative effects;
a positive mean implied a dominance of positive effects. A
mean close to 0 could result from either many neutral ef-
fects (whereby a pathogen consistently had no discernible
effect) and/or equal numbers of positive and negative
effects (whereby a pathogen had different, possibly
Figure 1 Annual coinfection publications (log10) from initial
Scopus search. See the Methods section for search criteria.
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clear indication of these pathogens having a consistent ef-
fect on each other (or on host health), so we adopt the
most conservative interpretation and assume there is no-
effect. These means were converted into three categories:
negative (1 to 1/3 ), neutral (1 to þ1/3 ) and positive
(þ1/3 to þ1). Chi-squared tests24 based on double log-
likelihood values25,26 were done to establish whether totals
in each category differed from those expected from two
different null hypotheses (random and no-effect). The ran-
dom null model was of equal proportions of positive, neu-
tral and negative effects, while the no-effect null model
was that coinfecting pathogens do not interact, allowing
for a 5% error rate (hence 2.5% negative, 2.5% positive,
and 95% neutral reported effects). This constitutes a recom-
mended vote-counting method deriving continuous param-
eters analysed against confidence intervals (a Z 0.05).27
Finally, we explored the potential influence of the
missing data (NAs) on the effects of coinfection in the
analysis (56 for pathogen abundance, 79 for host health).
These values represent reported coinfections where the
effect on either pathogen abundance or host health was not
reported, despite the possibility that these coinfecting
pathogens did interact with each other and/or influence
host health. We therefore assessed how potential interac-
tions from these unreported effects may alter the overall
patterns of coinfection effects. To determine their poten-
tial impact on the estimated overall effects, NAs were
assigned one of three values at random (þ1, 0, 1). The
mean effect was then calculated per publication or co-
infection pair as before, and a grand mean taken across all
publications or coinfection-pairs. The grand mean repre-
sents an estimate of overall effect of coinfection on either
host health or pathogen abundance across either publica-
tions or coinfections, given a particular random assignment
of 1, 0, þ1 to NAs. Repeating this random assignment 1000
times produced a distribution of grand means.
Comparison with WHO data
We examined whether recent coinfection research focuses
on the pathogens causing the highest global mortality. We
obtained global totals for the number of deaths (both
sexes, all ages) in 2009 under every category of infection
collated by the World Health Organisation (obtained from
the Global Burden of Disease section of the Global Health
Observatory website).28 We compared the ten categories
causing most global deaths in 2009 with total reports of co-
infection involving these infections. Comparing the top ten
infection categories by mortality with their morbidity mea-
sures (DALYs) yielded similar trends, so we present only
data from the mortality comparison.
Results
Overall trends in coinfection publications
Hundreds of publications on coinfection are published annu-
ally and have increased from 219 publications in the first year
of search results to 1464 publications in 2009 (Fig. 1). This in-
crease includes studies of both human and non-human hosts.Of the 1464 publications retrieved for 2009, 309 reportedmul-
tiple pathogen species coinfecting humans. Publications
came from 192 journals, with most (136 of 192 journals,
70.8%) publishing a single coinfection article in 2009.
The majority of relevant publications from 2009 were
observational studies (234 of 309, 75.0%), of which 159
(67.9%) involved patient groups, 60 (25.6%) were case notes
and 18 (7.7%) surveyed a population. Three observational
studies (1.3%) analysed death records. Seventy publications
(22.4%) were reviews or metaanalyses. Five publications
(1.6%) were experimental, whereby treatment and controls
were applied to both singly infected and coinfected groups.
A majority of the relevant publications concerned coinfec-
tions by two pathogen species (249 of 309, 80.5%), but more
pathogen species per individual were occasionally re-
ported; the mean number of pathogens was 2.4 and
a maximum of 13 pathogens was reported twice in a venous
leg ulcer29 and a periodontal infection.30
Reported coinfecting pathogens
A total of 270 pathogen taxa were reported in coinfection
publications from 2009, across 1265 reports of coinfections
comprising 933 different pairs of coinfecting pathogen
taxa. All pathogen types (viruses, bacteria, protozoa,
fungal parasites, helminths) were reported in coinfections;
the most common pathogen group was bacteria (Table 1). In
terms of specific pairs of reported coinfecting pathogens
there was high diversity, but HIV and hepatitis viruses fea-
tured relatively highly (Table 1).
Effects of coinfection on pathogen abundance and
human health
Effects of coinfection on pathogen abundance and host
health were sampled across 173 suitable publications
according to pathogen abundance and host health. These
publications covered 827 coinfecting pairs of pathogens,
Table 1 Number of reports of each type of pathogen and
the five most reported pairs of coinfecting pathogens among
2009 coinfection publications.
Pathogen
Type
Frequency
(%)
Coinfecting
pathogens
Frequency
(%)
Bacteria 1351 (53.4) HCV-HIV 82 (6.5)
Viruses 877 (34.7) HBV-HIV 31 (2.4)
Protozoa 117 (4.6) HBV-HCV 30 (2.4)
Helminths 78 (3.1) HIV-Mtb 28 (2.2)
Fungi 81 (3.2) HIV-HPV 27 (2.1)
HBV Z Hepatitis B Virus, HCV Z Hepatitis C Virus,
HIV Z Human Immunodeficiency Virus, Mtb Z Mycobacterium
tuberculosis, HPV Z Human Papillomavirus.
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203 (24.5%) measured the size or direction of effects on
pathogen abundance and 191 (23.1%) measured the size or
direction of effects on host health. The remainder of
coinfections had no reports of the effects of coinfection
in suitable publications.
Overall, positive effects of coinfection on pathogen
abundance were the most common reported across publi-
cations (6 negative, 15 neutral, 28 positive reports across
49 publications; Fig. 2A). Among specific pairs of coinfect-
ing pathogens neutral effects exceeded positive effects
(10 negative, 95 neutral, 69 positive across 174 uniqueFigure 2 Direction of reported effects of coinfection on the abu
publications and coinfections published in 2009. Horizontal lines in
grey Z random).pathogen pairs; Fig. 2C). In both cases these patterns
were strongly significantly different from both the random
null model (grey line on Fig. 2, by publication [X2 Z 15.6,
d.f. Z 2, P < 0.001] and by coinfection [X2 Z 82.6,
d.f. Z 2, P < 0.001]) and from the no-effect null model
(black line on Fig. 2, by publication [X2 Z 160.3,
d.f. Z 2, P < 0.001] and by coinfection [X2 Z 292.8,
d.f. Z 2, P < 0.001]).
Regarding the impact of coinfection on host health,
there was a much greater number of negative effects
reported in publications than either positive, neutral or
NA categories (51 negative, 12 neutral, 4 positive across 67
publications; Fig. 2B). When data were aggregated by spe-
cific pathogen pairs the neutral effects exceed the negative
effects (51 negative, 84 neutral, 5 positive across 140
unique pathogen pairs; Fig. 2D). In both cases these pat-
terns were significantly different from both the random
null model (grey line, by publication [X2 Z 55.6,
d.f. Z 2, P < 0.001, Fig. 2B] and by coinfection
[X2 Z 85.5, d.f. Z 2, P < 0.001, Fig. 2D]) and from the
no-effect null model (black line, by publication
[X2 Z 315.4, d.f. Z 2, P < 0.001, Fig. 2A] and by coinfec-
tion [X2 Z 199.6, d.f. Z 2, P < 0.001, Fig. 2C]).
It is unlikely that these patterns of the effects of
coinfection would be changed by knowledge of the un-
reported effects (the NAs in Fig. 2). Even after NA values
were assigned predominantly to the neutral category (i.e.
under the no-effect null model), the distribution of the
grand mean effect was positive for the effects on pathogenndance of infecting pathogens and host health averaged across
dicate expected values of null hypotheses (black Z no-effect,
Figure 4 Top ten infections from global mortality data (28)
(grey bars), compared with percentage of times the infections
were reported in coinfections in 2009 publications (black bars).
204 E.C. Griffiths et al.abundance (Fig. 3A and C), and negative for effects on host
health (Fig. 3B and D). None of the distributions of grand
means overlapped zero (Fig. 3).
Do coinfection studies focus on the most important
infectious diseases?
We found notable differences between the most commonly
reported coinfecting pathogens and the infections causing
the greatest global health burden (Fig. 4). The largest in-
fectious causes of mortality are respiratory infections,
causing 44.7% of these deaths with the next greatest
causes, diarrhoea and HIV/AIDS, causing half as many
deaths. Other important infections by global mortality
are tuberculosis, malaria and childhood infections (mea-
sles, meningitis, whooping cough and tetanus). The tenth
biggest infectious cause of mortality worldwide, HBV, is
the only hepatitis virus featuring in the top ten infectious
causes of mortality, causing 1.1% of infectious disease
deaths. In comparison, hepatitis viruses featured in one
fifth of reported coinfections (286 of 1265, 22.6%). The
top ten pathogen species reported in coinfections were
HIV (in 266 [21.9%] of 1265 coinfections), HCV (11.4%),
HBV (7.04%), Staphylococcus aureus (4.58%), Escherichia
coli (4.43%), Pseudomonas aeruginosa (3.72%), Mycobacte-
rium tuberculosis (5.9%), HPV (3.16%), unidentified Strep-
tococcus spp. (3.00%), and unidentified Staphylococcus
spp. (3.00%). Some of the most common reported coinfect-
ing pathogens (HCV, Staphylococcus, HPV, and Streptococ-
cus) contribute relatively little to global infectionFigure 3 Distribution of grand mean effects of coinfection includ
line) and no-effect (black line) null models. Lines generated by a
Z 5.1  103, no-effect Z 1.2  103).mortality. Perhaps surprisingly, four of the most important
infectious causes of mortality (all of them childhood infec-
tions) received very few or no reports of coinfection in
2009 publications.ing simulations of missing values according to the random (grey
Gaussian kernel estimator (smoothing bandwidths: random-
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Interest in coinfection has increased in recent years, with
publications on human coinfection involving hundreds of
pathogen taxa across all major pathogen groups. Recent
publications tend to show that negative effects of coinfec-
tion on human health are more frequent than no-effect or
positive effects. However, the most commonly reported
coinfecting pathogens differ from those infections causing
highest global mortality. These results raise questions
concerning the occurrence and study of coinfection in
humans and their implications for effective infectious
disease management.
The overall consequence of reported coinfections was
poorer host health and enhanced pathogen abundance,
compared with single infections. This is strongly supported
by significant statistical differences in the reported di-
rection of effects (P < 0.001) from expectations of either
no-effect or of random distributions, and by the robustness
of these trends in the face of missing values and by diversity
in the types of publications in which these coinfections
were reported. Moreover the tendency for positive effects
on pathogen abundance corroborates the negative effects
on host health because larger infections are a mechanism
by which disease can be exacerbated. The consistency of
these detrimental coinfection effects across a wide range
of pathogens suggests a general incidence of interactions
between coinfections. The long-term effects among survi-
vors of coinfections can be varied and in some cases severe,
including blindness, chronic diarrhoea, chronic inflamma-
tion, carcinoma, immunosuppression, liver fibrosis, menin-
gitis, renal failure, rheumatic fever, etc.31
The direction of reported coinfection effects could have
at least two explanations. The first is that coinfection may
be more likely in individuals of poor health, which in turn
leads to poorer prognosis among coinfected cases. The
relative paucity of experimental studies of coinfection in
humans means sampling biases towards people of poorer
health is possible, but impossible to account for in our
analyses. The second explanation is that coinfecting path-
ogens interact synergistically with each other, for example
via the host’s immune system, so that the presence of one
enhances the abundance and/or virulence of the other. A
clear example of this is HIV, which causes immunosuppres-
sion, increasing the likelihood of additional infections and
occurred in two fifths of reported coinfections (Fig. 4).
Differences between reported coinfections and global
mortality figures may also suggest important interactions
between coinfecting pathogens. Coinfections that were
more commonly reported than their relative contribution
to global mortality may involve particular synergistic
pathogenepathogen interactions, such as among herpes
viruses like CMV or HSV infection enhancing the risk of HPV
coinfection.32 Conversely, infections that cause high mor-
tality but had relatively few reports of coinfection could re-
sult from antagonistic interactions, reducing the likelihood
of such coinfections occurring and being reported, like P.
aeruginosa exoproduct limiting S. aureus colony forma-
tion.33 An alternative and possibly more likely explanation
of the discrepancies between reported coinfections and
global mortalities from infections could be greater fundingavailability (e.g. HIV/AIDS research), higher interests of vi-
rologists in coinfection and/or easier observations or more
routine screening compared with other pathogens, for in-
stance the greater difficulty of detecting intestinal hel-
minths in coinfection research. The lack of coinfection
publications reporting on major infectious causes of child-
hood mortality remains unexplained. While some publica-
tions do study childhood coinfection and find coinfection
to be more common in children,34 current coinfection re-
search does not include the infections that kill the most in-
fants globally. Fewer than 1 in 20 publications reported
coinfections involving helminths, despite hundreds of mil-
lions of helminth coinfections globally,6 which could arise
from limited published research on helminthiases. To
what extent disparities between global mortality data re-
flect actual epidemiology or biases in research attention re-
mains to be established, in part hindered by current
inadequacies in coinfection surveillance.
The disparity between infections that feature highly in
global mortality statistics and those receiving most atten-
tion in published coinfection studies poses a challenge to
infectious disease research. A general understanding of the
effects of coinfection is important for appropriate control
of infectious diseases.4,7,8,35 Poor or uncertain observa-
tional data regarding coinfection hinders efforts to improve
health strategies for infectious disease in at-risk popula-
tions.9 For example, global infectious disease mortality
data28 report only single causes of death, even if comorbid-
ities were identified. If health statistics better represent
coinfection, published coinfection research could be better
evaluated. Moreover there is a lack of coherence in coin-
fection literature, with a variety of synonyms being used
for the same phenomenon, which is multi-species infection
(see the Methods for examples). The term polymicrobial,
while commonplace, is restricted to coinfections involving
microbes. Coinfection is a broader term encompassing all
pathogen types including interactions between the same
kinds of pathogens as well as cross-kingdom coinfections
between, say, bacteria and helminths. Ultimately decisions
over which term to prefer (if any) need to be made by a con-
sensus of the diverse research communities concerned with
this phenomenon. True patterns of coinfection remain un-
known21 and our results suggest that it may be starkly dif-
ferent from existing data on important infectious diseases.
Overall recently published reports of coinfection in
humans show coinfection to be detrimental to human
health. Understanding the nature and consequences of
coinfection is vital for accurate estimates of infectious
disease burden. In particular, more holistic data on in-
fectious diseases would help to quantify the size of the
effects on coinfection on human health. Improved knowl-
edge of the factors controlling an individual’s risk of coin-
fection, circumstances when coinfecting pathogens
interact, and the mechanisms behind these patho-
genepathogen interactions, especially from experimental
studies, will also aid the design and evaluation of infectious
disease management programmes. To date, most disease
control programs typically adopt a vertical approach to in-
tervention, dealing with each pathogen infection in isola-
tion. If coinfecting pathogens generally interact to worsen
human health, as suggested here, control measures may
need to be more integrated and specialist treatments
206 E.C. Griffiths et al.developed for clinical cases of coinfection. Further re-
search is needed to identify the role of predisposed risks
to coinfection.
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